The nomogram to predict lymph node involvement for prostate cancer was developed using known prognostic factors, including pretreatment prostate-specific antigen (PSA), Gleason score, and clinical stage as the key factors for estimating the risk of lymph node metastasis [14, 15]. This evidence concerns the gene KLK3 and metastatic malignant neoplasm in the lymph nodes.